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Protein provision in critically ill adults requiring enteral nutrition: Are 
guidelines being met? 
 
Abstract 
Background: In a previous audit, 81% of enteral protein prescriptions failed to meet protein 
guidelines. To address this, a very high protein enteral formula and protein supplements 
were introduced, and protein prescriptions were adjusted to account for non-nutritional 
energy sources displacing enteral formula. This follow-up audit compared protein provision 
in critically ill adults requiring exclusive enteral nutrition (EN), firstly, to local and international 
guidelines and, secondly, following changes to practice, with the previous audit in the same 
ICU. 
Methods: Data collected from 106 adults consecutively admitted to the ICU of a UK tertiary 
hospital and requiring exclusive EN ≥3 days. Protein targets based on local guidelines (1.25, 
1.5 or 2.0g/kg/day), nutrition prescription and delivery were recorded for 24-hours between 
days 1-3, 5-7, 8-10, and 18-20 post-ICU admission. 
Results: On day 1-3, the proportion of protein prescriptions meeting protein targets 
increased from 19% in 2015, to 69% in 2017 (p<0.0005, phi=0.50). Nutrition delivery met 
protein targets for only 22% of patients. For all patients, on average, prescriptions met 103% 
of the protein target, and 79% of the protein target was delivered (p<0.0005, r=0.53). The 
proportion of protein prescriptions meeting protein targets was similar for days 1-3 (69%), 5-
7 (71%), and 8-10 (68%), but increased slightly by day 18-20 (74%). The proportion of 
patients for which EN delivery met protein targets increased with number of days post-ICU 
admission (22%, 26%, 37%, and 53% for day 1-3, 5-7, 8-10, and 18-20, respectively).  
Conclusion: The proportion of protein prescriptions meeting guideline targets was higher 
following changes to practice. 
Keywords: critical care; enteral nutrition; protein; overfeeding; nutritional requirements 
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Introduction 
Catabolism of lean body mass during critical illness is associated with impaired immunity 
and wound healing, and weakness (1-4). Catabolism mobilises energy substrates and amino 
acids to maintain the acute-phase protein response (5). Nutrition, particularly protein, is key 
in attempting to minimise catabolism and maintain the acute-phase protein response during 
critical illness (5). Observational prospective cohort studies show an association between 
increased protein provision (≥1.2g/kg/day) and improved clinical outcomes (6-8), but exact 
dose and timing have not been defined (9). 
Currently, for critically ill adults, the American Society for Parenteral and Enteral Nutrition 
(ASPEN) recommends 1.2-2.5g/kg/day of protein, and 2.0-2.5g/kg ideal body weight 
(IBW)/day if BMI is >30kg/m2 (10); the European Society for Clinical Nutrition and 
Metabolism (ESPEN) recommends 1.3-1.5g/kgIBW/day (11). This compares to the 
Recommended Dietary Allowance (RDA) for protein intake in healthy adults of 0.8g/kg/day 
(12).  
It is difficult to achieve these goals without overfeeding energy (13) because the non-protein 
energy to nitrogen ratio (NPE:gN) of most enteral formulas and common use of non-
nutritional energy (NNE) sources, such as Propofol and citrate regional anticoagulation, are 
too high (14). 
Randomised controlled trials (RCTs) are required to define the effect of dose and timing of 
protein provision on clinical outcomes. However, we first need to establish how to provide 
high levels of protein without overfeeding energy. 
There is a large deficit between protein guidelines versus prescription (14), and 
enteral/parenteral protein prescription versus delivery in intensive care units (ICU) worldwide 
(15-17). In a previous audit in the study ICU, only 19% of enteral protein prescriptions met 
local guidelines (14). It was shown that, in theory, use of protein supplements and 
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adjustment of protein prescriptions for NNE could significantly increase the proportion of 
patients meeting protein guidelines (14). 
As far as the authors are aware, no studies have compared both prescription and delivery of 
protein, to guidelines in critically ill adults. Following on from the audit of enteral protein 
prescriptions reported by Taylor et al. (14) at the same ICU, this follow-up audit determines 
whether protein targets, based on guidelines (see Methods, Table 1), are met by enteral 
nutrition (EN) prescriptions and delivery, since implementing improvements in prescribing 
practice and EN products. 
For the purpose of this study, nutrition prescription is defined as the total nutrition prescribed 
from enteral formula, supplements and NNE sources per day. Nutrition delivery is the total 
nutrition actually provided to the patient from enteral formula, supplements and NNE sources 
per day. 
Aims: 1) to compare protein provision in critically ill adults requiring exclusive EN (via feeding 
tube) to local and international guidelines; 2) to provide a comparison with the previous audit 
of protein prescriptions in the same ICU following changes to practice. 
 
Methods 
Changes to practice in EN provision 
Previous practice at the study ICU was for EN to be prescribed to meet the protein goal 
when no NNE was delivered. This meant that until NNE (usually Propofol) stopped, EN was 
limited to prevent overfeeding, therefore protein goals were often not met. The highest 
protein enteral formula available on the ICU was Nutrison Protein Plus (Nutricia, Wiltshire, 
UK; 6.3g protein, 14.2g carbohydrate, 125kcal per 100ml; NPE:gN 99:1). No protein 
supplements were stocked for use on the ICU. 
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Following the findings of the previous audit (14), where possible, dietitians prescribed EN to 
meet the full protein target accounting for a reduced rate of enteral formula delivery due to 
the presence of Propofol. This was facilitated by using a protein supplement (ProSource® 
TF; Nutrinovo, Kent, UK; 11g protein, 1g carbohydrate, 44kcal per 45ml) and/or a very high 
protein enteral formula (Fresubin® Intensive; Fresanius Kabi, Cheshire, UK; 10g protein, 
12.9g carbohydrate, 122kcal per 100ml; NPE:gN 51:1). Where the volume of enteral formula 
prescribed was less than the nutritionally complete volume, to provide basic micronutrient 
requirements, a soluble multivitamin was also prescribed. 
Participants 
Adults (≥18y) admitted to the ICU of a tertiary hospital in the UK between 22nd April 2017 
and 12th July 2017 were included prospectively if they required exclusive EN on ICU 
admission. Exclusion criteria were: exclusive EN no longer required or discontinued, or the 
patient discharged from ICU, within 72 hours of admission; patient not referred to the 
dietitian for EN within 72 hours of admission; clinical EN or protein restriction e.g. high 
refeeding risk, renal impairment requiring conservative management, liver dysfunction 
refractory to treatment, or GI dysfunction; PN indicated; oral nutrition commenced; or 
palliative care. 
Data collection 
Patient characteristics were recorded on admission. Weight and height were taken from the 
patient’s notes and were usually estimated or based on relatives’ report or previous General 
Practitioner’s (GP) or hospital records.  
Nutritional assessment and prescriptions were completed, and reviewed daily Monday to 
Friday, by experienced critical care dietitians. Resting metabolic rate (RMR), used to 
calculate estimated energy requirement (EER), was estimated using validated predictive 
equations for ventilated critically ill adults (18) and non-ventilated acutely ill adults (19), 
based on changing physiological parameters as well as body weight. For non-ventilated 
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burns patients, the validated Toronto equation was used when deemed most appropriate by 
the dietitian (20). 
Dietitians estimated individualised protein targets based on local guidelines. Local and 
international guidelines for protein provision in critically ill adults are shown in Table 1. For 
patients with BMI>25kg/m2, an IBW equivalent to a BMI of 25kg/m2 was used when 
calculating protein targets using local guidelines. Local guidelines span most of the range 
recommended in the ASPEN guidelines and therefore identifying whether protein 
prescriptions and delivery met protein targets based on local guidelines also shows whether 
ASPEN guidelines for protein provision can be met (10). 
Nutritional data were collected for one day during each of the following time periods in a 
patient’s ICU stay: days 1-3, 5-7, 8-10, and 18-20. Day 1-3 of ICU stay was the primary data 
collection period, as protein prescriptions aimed to match target from day 1, and all patients 
included required exclusive EN for ≥3 days. The first day audited for each patient was the 
first full day on the ICU after the patient had been assessed and target EN prescribed by a 
dietitian. The primary data collection period, day 1-3, matches that used in the 2015 audit, 
enabling direct comparison (14). Data collection was discontinued early if the patient no 
longer met the inclusion criteria. 
Data was collated from patient dietetic records. Nutritional data collected were: energy and 
protein targets based on local guidelines; equation used to calculate EER; reason for 
hypocaloric feeding, if appropriate; predicted and delivered NNE (Propofol, IV glucose, 
citrate); nutrition prescription; enteral formula, supplements, and enteral fluid administered; 
gastric residual volumes (GRV) discarded or vomited. For patients on continuous renal 
replacement therapy (CRRT) receiving citrate as anticoagulant in the continuous 
venovenous haemofiltration (CVVH) solution, it was assumed that they received an 
additional 200kcal/day, as it was not possible to determine individualised values (21).  
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The protein prescription was calculated from the volume of enteral formula and supplements 
prescribed. Protein delivery was the amount of protein actually received by the patient in the 
enteral formula and supplements administered, minus gastric losses. In calculating nutrition 
delivery, gastric losses were accounted for, to identify how much exogenous protein was 
received into the small intestine and was therefore available for absorption. 
Nutritional adequacy 
Nutritional adequacy criteria were defined as ≥90% of the protein target and ≥130g/day 
carbohydrate (obligatory glucose requirement) (12) without overfeeding energy (≤100% 
EER), as used in the 2015 audit (14). The protein supplement provides protein in increments 
of 11g and therefore prescriptions could rarely achieve exactly 100% of protein target. The 
number of protein supplements prescribed was rounded down and therefore the value of 
≥90% of protein target was chosen to match protein goals associated with improved clinical 
outcomes in mechanically ventilated, critically ill adults (>90% of 1.2-1.5g/kg/day or based 
on nitrogen balance) (8).. It was assumed this optimises protein utilisation, minimising 
reliance on gluconeogenesis of amino acids and glycerol (14). The final adequacy criteria 
required that energy from all sources was ≤100% of EER, to avoid consequences of 
overfeeding (22, 23); obese patients received hypocaloric prescription, well below 100% of 
EER but with adequate protein to minimise catabolism (10, 24). Results from analyses 
considering nutritional adequacy can be found in supplementary material (Table S1). 
Statistical analyses 
Variables were assessed for normal distribution using Q-Q plots and the Shapiro-Wilk test. 
Continuous variables that were normally distributed are described as mean ±SD. Non-
normally distributed continuous variables are described as median with interquartile range 
(IQR). Categorical variables are described as a percentage. 
Fisher’s exact test was used to compare the proportion of protein prescriptions meeting 
protein targets based on local guidelines in the current audit to the 2015 audit (14), and phi 
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calculated to identify effect size. Wilcoxon’s signed rank test, with calculation of effect size r, 
was used to compare the difference between protein targets and protein prescriptions, and 
protein targets and protein delivery. Wilcoxon’s signed rank test was also used to compare 
the difference in the percentage of protein target met by prescription versus the percentage 
of protein target met by delivery. Continuous variables were compared between the 2015 
and 2017 samples using the Mann Whitney U test, with calculation of effect size r. The Mann 
Whitney U test was also used to compare continuous variables in subgroup analysis. 
Categorical variables were compared between the same independent samples using 
Fisher’s exact test with phi or Cramer’s V reported as effect size, as appropriate. Subgroup 
analysis compared groups based on previously identified risk factors for failing to achieve 
protein targets (14). All statistical tests performed were two-tailed. Magnitude of effect sizes 
were determined based on Cohen’s guidelines: 0.1 = small, 0.3 = medium, 0.5 = large (25). 
Guidance from the National Audit Office suggests that a sample size of 100 is sufficient for 
most audit purposes (26). A sample of 106 patients was included in the primary analyses for 
day 1-3 post ICU admission. A retrospective sample size calculation showed that, for the 
proportion of the sample identified as achieving the standard (protein targets based on local 
guidelines) with protein prescription, and protein delivery, and with this sample size of 106 
patients, accuracy was approximately ±8% with a confidence level of 95% (27). 
Ethics 
This project was accepted and registered as an audit by the local NHS Trust and the 
University to which authors were affiliated. NHS ethics approval was not required as all audit 
data were routinely collected for clinical purposes. 
 
Results 
Sample characteristics 
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One hundred and six ICU patients requiring exclusive EN were included (Table 2). The 
majority of patients had a protein target of 1.25g/kg/day based on local guidelines (Table 3). 
Baseline characteristics of patients included in the 2015 (14) and 2017 audits were similar 
(Table 2). The large proportion of trauma and neurosurgery patients reflects the hospital 
being a regional major trauma centre. 
Protein prescription and delivery compared to guidelines 
The proportion of protein prescriptions meeting protein targets based on local guidelines on 
day 1-3 of ICU admission increased from 19% (n=27/139) in 2015 to 69% (n=73/106) in 
2017, with large effect size (p<0.0005, phi=0.50). 
A higher percentage of patients’ protein target was prescribed in 2017 compared to 2015 
(median 103%, IQR 97-108, versus 75%, IQR 62-95; p<0.0005, r=0.54: large effect size). In 
the 2017 audit, 99% (105/106) of protein prescriptions achieved over 75% of their protein 
target with prescription, the median proportion achieved in the 2015 audit. Protein targets in 
2015 were slightly higher than in 2017 (median 108.3g/day, IQR 84.4-129.2, versus 
97.2g/day, IQR, 84.0-116.4; p=0.135, r=0.09: small effect size; normalized: median 
1.32g/kg/day, IQR 1.10-1.88, versus 1.25g/kg/day, IQR 1.17-1.50). 
Figure 1 shows a comparison over time between the percentage of protein prescriptions 
meeting protein targets based on local guidelines and the percentage of patients meeting 
protein targets with EN delivery. 
The median protein prescription on day 1-3 was 3g higher than the protein target, but not of 
clinical significance . Protein delivery on day 1-3 was lower than protein target (median 79g 
versus 97g, z=-6.89, p<0.0005, r=0.47: medium-large effect size) with the difference of 18g 
between median protein target and delivery being potentially clinically significant (Figure 2). 
Median percentage of protein target met by delivery on day 1-3 was 79% versus 103% for 
the percentage of protein target met by prescription (z=-7.70, p<0.0005, r=0.53: large effect 
size). 
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Complete data for energy and protein targets, prescription and delivery can be found in 
Table S2. 
Risk factors for inadequate EN 
Patients with the highest protein target, 2.0g/kg/day, were less likely to meet their protein 
target with prescription (46% versus 79% and 75% for targets of 2.0, 1.5 and 1.25g/kg/day 
respectively, p=0.027, Cramer’s V=0.27: medium effect size). For delivery, there was a trend 
in the same direction (12% versus 21% and 25% for targets of 2.0, 1.5 and 1.25g/kg/day 
respectively, p=0.489, Cramer’s V=0.13: small effect size). 
Patients prescribed hypocaloric nutrition due to obesity or metabolic intolerance were more 
likely to meet their protein target with prescription (84% versus 66%, p=0.171, phi=0.155: 
small effect size). The same analysis could not be done for delivery due to insufficient 
numbers in some groups. 
For delivery, NNE as a percentage of total energy was higher in the group that failed to meet 
their protein target compared to those who met their protein targets (median 10%, IQR 0-23, 
versus 6%, IQR 0-9, U=680, z=-1.922, p=0.055, r=0.19: small effect size). 
 
Discussion 
Changes in prescribing practices, made in response to the 2015 audit (14), were associated 
with more protein prescriptions meeting protein targets based on local guidelines, increasing 
from 19% (2015) to 69% (2017); the slightly lower protein targets in 2017 are unlikely to 
have contributed significantly.  
The proportion of protein prescriptions meeting targets was similar over the first 10 days of 
ICU admission (68-71%) with a small increase by day 18-20 (74%). It is likely that this was 
partly due to a reduced proportion of patients with higher protein targets (1.5 or 2.0g/kg/day) 
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at day 18-20 and a reduction in NNE permitting easier attainment of protein targets without 
overfeeding. 
There was a trend for protein targets not to be met by prescriptions in patients with the 
highest protein targets (2.0g/kg/day). At the time of this follow-up audit, dietitians tended to 
round down the number of protein supplements prescribed making it more likely that patients 
would be slightly under-prescribed rather than over-prescribed protein. Due to the common 
under-delivery of EN, it may be beneficial to encourage dietitians to round up the number of 
supplements. Patients with high BMI, and therefore requiring hypocaloric feeding, were at 
increased risk of not meeting protein targets and the obligatory glucose requirement in the 
2015 audit (12) but not in the follow-up audit.. 
As seen in previous studies, there was a large gap between protein prescription and delivery 
(15, 16). Only 22% of patients actually received their protein target on day 1-3, but this 
increased to 53% by day 18-20. Median percent of protein target met by EN delivery, on day 
1-3 of ICU admission, was 79% (IQR, 54-99) compared to 103% (IQR, 97-109) with 
prescription. Whereas the prescription IQR was narrow and straddled 100%, the IQR for 
delivery was wide and below 100% showing that non-prescription factors impair the meeting 
of targets. These factors were not investigated in the current study but have been reported 
elsewhere to commonly include delays for tests and procedures, GI intolerance, and feeding 
tube problems (28). Improvement in EN delivery with number of days post ICU 
admission has also previously been described (7), and is likely due to improvements in 
GI tolerance, and reduced delays for procedures (28).  
Further research is needed to investigate ways to improve EN delivery. Specifically, issues 
with enteral access and GI intolerance that limit EN delivery need to be investigated. We 
need to identify safe and effective solutions to reduce the frequency and severity of these 
problems or to provide alternative methods for delivering EN that bypass these issues. 
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Where EN prescriptions still fail to meet requirements in some cases, specific clinical 
reasons such as biochemical abnormalities and organ dysfunction need to be investigated. 
High NNE provision was the main risk factor for failing to meet protein target with EN 
delivery on day 1-3. Protein prescriptions were adjusted for predicted NNE, but when NNE 
delivery was higher than predicted, enteral formula and therefore protein delivery would be 
reduced, preventing protein target being met. Raising awareness of the impact of NNE 
sources on patients’ nutrition amongst the ICU multi-disciplinary team is important to 
facilitate changes that may be implemented to reduce the amount of NNE, for example 
changing type and/or dose of sedatives and IV fluids/solutions. 
Local protein guidelines (1.25, 1.5, or 2.0g/kg/day based on CRP level) span most of the 
range recommended by ASPEN (1.2-2.5g/kg/day), therefore the factors suggested to affect 
protein prescription and delivery should largely apply to protein targets based on ASPEN 
guidelines (10). Lack of objective criteria for choosing an individual’s protein target risk 
arbitrary choice between 1.2-2.5g/kg/day; to avoid this, local guidelines match target to CRP 
level based on the consensus that higher input is of benefit in more severe illness. The 
current and previous audit carried out on the same ICU (14) are the only studies that have 
directly compared protein prescription to guideline targets. The most recent published data 
from the International Nutrition Survey (INS) report protein adequacy (percent of prescription 
met by delivery) for artificial nutrition (EN and PN) of 57.6% for all countries, and 69.8% for 
Europe and South Africa (16). In the current audit, median percentage of protein target 
achieved with EN delivery was 79% and 102% on days 1-3 and 18-20, respectively.  
The relative improvement of the current audit over INS results may be even larger because 
of differences in the way that data were collected and analysed. Although most INS patients 
were prescribed EN, delivery for those on PN was likely to be closer to prescription (15, 16). 
Mean protein prescription (±SD) was 1.2g/kg/day ±0.3 in the INS (16) compared to higher 
and harder to attain protein targets of 1.25-2.0g/kg/day in this audit. In this audit, EN delivery 
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was adjusted for gastric losses, providing a more valid measure of the nutrition available to 
the patient for absorption. In contrast, exclusion of patients commencing partial oral intake 
from the current audit may have contributed to higher reported delivery in comparison to the 
INS. 
A retrospective USA audit recorded protein adequacy from EN at day 3 of ICU admission, 
providing a similar comparison to day 1-3 delivery in the current audit (17). Protein adequacy 
was only 17% for the American sample of mostly medical ICU patients (17). The current 
audit was at a major trauma centre and therefore included a large proportion of trauma and 
neurosurgery patients. In the American audit, only 9% of patients audited received 80% or 
above of their protein prescription on day 3, compared to 22% of patients in the current audit 
who received 100% of their protein target based on local guidelines, on day 1-3 of ICU 
admission (17).  
Prospective cohort studies carried out in the Netherlands report a higher proportion of 
patients achieving their protein target with EN delivery (6, 29). Weijs et al. (6) report that 
30% of patients achieved at least 1.2g/kg/day during the period of mechanical ventilation 
when targets were set at 1.2-1.5g/kg/day. This is higher than the current audit on day 1-3 
(22%), but by day 18-20 53% met their protein target and these targets were higher (1.25-
2.0g/kg/day) and therefore more difficult to achieve.  
The findings of the current audit, and other literature in this area, indicate that it is important 
for ICUs to audit their EN prescriptions and delivery to identify potential deficits. Based on 
this follow-up audit, it is suggested that protein deficits may be reduced significantly by the 
availability of a very high protein enteral formula and an enteral protein supplement. 
Consideration of the displacement of EN by NNE sources such as Propofol is important, 
particularly early in a patient’s ICU stay, and protein prescriptions should be adjusted 
accordingly. 
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Prescribing adequate protein without overfeeding energy or restricting other nutrients such 
as carbohydrate, electrolytes and micronutrients is a difficult balancing act. The ability to 
prescribe (and potentially therefore deliver) a balance of EN that is optimal for the critically ill 
patient is more likely to be achieved when the prescriber has access to both a range of 
enteral formulas that includes one with a low NPE:gN ratio, and protein supplements easily 
administered via an enteral feeding tube. Further education of dietitians, physicians, and 
nurses is required to increase awareness of the potential for large nutritional deficiencies in 
ICU patients and changes they can make towards optimal prescribing and delivery of EN. 
A limitation in this audit was the use of estimated or reported admission weight where no 
recent actual weight had been recorded. This represents a source of error in calculations of 
BMI, EER, and protein targets. However, use of estimated or reported weights reflects real 
world circumstances where accurate current weights are rarely available for critically ill 
patients.  
In calculating EN delivery, the assumption that all GRV loss was enteral formula or fluid will 
underestimate input because of unmeasurable dilution by saliva or gastric juice. Additionally, 
when using a nasointestinal tube, it was assumed that if EN appeared in the GRV it meant 
all nasointestinal EN was really gastric; this may overestimate loss. Currently there is no 
clinical method of more accurately accounting for GRV loss, but to ignore it would 
overestimate the percentage of target met. 
Another limitation is the small sample size available for the days 8-10 and 18-20 analysis 
due to the large number of patients meeting exclusion criteria by this point in their ICU stay. 
Larger patient numbers and testing of this protocol in other centres are required to determine 
whether the results are generalizable. 
In conclusion, a larger proportion of ICU EN prescriptions and delivery met their protein 
targets using protein supplements and a low NPE:gN ratio enteral formula (51:1) with protein 
prescriptions adjusted to the current NNE input, versus previous practice of adjusting protein 
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prescriptions to zero NNE and using NPE:gN ratio enteral formulas ≥99:1. It is therefore 
recommended that where patients require low NPE:gN ratios, enteral formula with a similar 
NPE:gN ratio and/or protein supplements should be stocked. 
 
 
Supplementary Material 
Tables S1 and S2 are available online at http://ncp.sagepub.com. 
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Table 1. Local and international guidelines for protein provision in critically ill adults 
Guideline  Protein g/kg/day 
Local trust guidelines CRP<100 1.25* 
CRP=100-149 1.5* 
CRP≥150 2.0* 
ESPEN guidelines (Singer et al., 2009)  1.3-1.5# 
ASPEN guidelines (McClave et al., 2016)  1.2-2.5 
Obese: BMI>30kg/m2 
             BMI>40kg/m2 
2.0# 
2.5# 
*use IBW if BMI>25kg/m2, #use IBW. CRP, C-reactive protein; IBW, ideal body weight; BMI, body mass index; ESPEN, 
European Society for Parenteral and Enteral Nutrition; ASPEN, American Society for Parenteral and Enteral Nutrition. 
 
Table 2. Comparison of baseline characteristics between 2015 and 2017 
      2015  
Taylor et al., 2016 (14) 
     n=139 
     2017 
      
    n=106 
 
Age, years* 59 ±18 58 ±17 p=0.532 
Sex male, n (%) 84 (60) 54 (51) p=0.154  
Weight, kg# 75.4 (65.0-88.0) 75.5 (64.9-89.6) p=0.841  
BMI, kg/m2 # 24.9 (22.6-28.7) 25.4  (22.5-28.7) p=0.768  
APACHE II score# 17 (13-23) 16 (11-22) p=0.359  
Diagnosis category, n (%) 
  Trauma 
  Neurosurgery (non-trauma) 
  Surgery (other) 
  Medical 
 
41  
29  
15  
54  
 
(29) 
(21) 
(11) 
(39) 
 
38  
27 
9 
32 
 
(36) 
(26) 
(9) 
(30) 
p=0.406  
*mean ±SD, #median (IQR). BMI, body mass index; APACHE II score, Acute Physiology and Chronic Health Evaluation II score; 
n, number of participants; SD, standard deviation; IQR, interquartile range. 
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Table 3. 2017 protein targets based on local guidelines 
Days post-ICU 
admission 
 
1.25g/kgBW*/day 
Protein target, n (%) 
1.5g/kgBW*/day 
 
2.0g/kgBW*/day 
Patients, n (%) 
1-3 63 (59) 19 (18) 24 (23) 106 (100) 
5-7 28 (43) 14 (22) 23 (35) 65 (61) 
8-10 22 (58)  6 (16) 10 (26) 38 (36) 
18-20 16 (84)  1 (5)  2 (11) 19 (18) 
*ideal body weight used if BMI>25kg/m2. ICU, intensive care unit; BW, body weight; n, number of participants; BMI, body mass 
index. 
 
Figure 1. Percentage of patients achieving protein targets with nutrition prescription and delivery 
 
Figure 2. Protein targets based on local and international guidelines compared to prescription and delivery 
Target=calculated daily requirement based on guidelines; Prescription=prescribed nutrition from enteral feed, supplements, and 
NNE; Delivery=actual nutrition received from enteral feed, supplements, and NNE. IQR, interquartile range; d, day post-ICU 
admission; BMI, body mass index (kg/m2); IBW, ideal body weight; ASPEN, American Society for Parenteral and Enteral 
Nutrition; ESPEN, European Society for Parenteral and Enteral Nutrition. 
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Table S1. Table of frequency of nutrition prescriptions and delivery meeting nutritional 
adequacy criteria 
Days post-ICU admission Number of prescriptions meeting 
adequacy criteria (%) 
Number for which nutritional 
delivery meets adequacy criteria (%) 
1-3 (n=106) 60 (57) 23 (22) 
5-7 (n=65) 37 (57) 19 (29) 
8-10 (n=38) 28 (74) 21 (55) 
18-20 (n=19) 15 (79) 13 (68) 
Adequacy criteria: ≥90% protein target; ≥130g/day carbohydrate; ≤100% EER. ICU, intensive care unit; EER, estimated energy 
requirement; n, number of participants. 
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Table S2. Table of nutrition outcomes 
 Day 1-3 Day 5-7 Day 8-10 Day 18-20 
 
Targetsa 
        
EER, kcal* 
 
1853  (1563-2147) 2014  (1658-2278) 2028  (1772-2283) 2124  (1887-2321) 
Protein target#, g* 
 
97.2  (84.0-116.4) 102.4  (87.4-128.0) 96.0  (80.9-128.1) 95.7  (81.3-105.8) 
 
Prescriptionb 
        
Protein, g* 
 
100.0  (86.6-120.0) 107.1  (92.1-130.0) 100.8  (88.2-127.5) 
 
100.8  (94.5-113.4) 
Protein, % of target* 
 
103  (97-108) 102  (96-110) 103  (99-113) 107  (99-119) 
Total energy, kcal* 
 
1757  (1586-2000) 1952  (1616-2103) 1952  (1740-2088) 1977  (1750-2250) 
Total energy, % of 
EER* 
99  (95-101) 99  (94-102) 99  (97-101) 97  (90-99) 
Energy from EN, kcal*  1625  (1427-1671) 1830  (1586-2037) 1875  (1669-2052) 1875  (1713-2250) 
% of total energy from 
EN* 
100  (85-100) 100  (90-100) 100  (100-100) 100  (100-100) 
Energy from NNE, 
kcal* 
0  (0-264) 0  (0-158) 0  (0-0) 
 
0  (0-0) 
% of total energy from 
NNE* 
0  (0-15) 0  (0-10) 0  (0-0) 0  (0-0) 
 
Deliveryc 
        
Protein, g* 
 
79.4  (50.4-99.6) 89.8  (75.8-109.0) 88.4  (74.5-119.1) 94.7 (82.3-102.4) 
Protein, % of target* 
 
79  (54-99) 
 
90  (74-105) 96  (83-107) 102  (95-112) 
Total energy, kcal* 
 
1299  (1051-1722) 
 
1636  (1199-1866) 
 
1731  (1488-1934) 1842  (1568-2026) 
Total energy, % of 
EER* 
74  (52-93) 85  (65-98) 89  (76-95) 92  (71-97) 
 
Energy from EN, kcal*  1225  (857-1671) 1569  (1177-1795) 1688  (1369-1864) 1813  (1531-2026) 
% of total energy from 
EN* 
92  (80-100) 98  (89-100) 100  (97-100) 100  (100-100) 
Energy from NNE, 
kcal* 
98  (0-229) 34  (0-186) 0  (0-52) 0  (0-13) 
% of total energy from 
NNE* 
8  (0-20) 2  (0-11) 0  (0-3) 0  (0-0) 
a target=calculated daily requirement, b prescription=prescribed nutrition from enteral feed, supplements, and NNE,                     
c delivery=actual nutrition received from enteral feed, supplements, and NNE, *median (IQR), # based on local protein 
guidelines. EER, estimated energy requirement; EN, enteral nutrition; NNE, non-nutritional energy; day, day post-ICU 
admission; IQR, interquartile range; ICU, intensive care unit. 
 
 
 
 
 
